Beijing, China

Moye Jia

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beijing Migrasome Therapeutics Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moye Jia. Retrieved from https://idiyas.com/inventor/moye-jia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Moye Jia: Innovator in Biomedicine

Introduction

Moye Jia is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedicine, particularly through his innovative work on engineered migrasomes. His research focuses on developing advanced delivery systems that can enhance therapeutic applications.

Latest Patents

Moye Jia holds a patent for an engineered migrasome, a method for preparing the same, and its various uses. This invention is crucial in the biomedicine sector, as it provides a novel approach to drug delivery systems. The patent emphasizes the preparation of engineered migrasomes and their potential applications in medical treatments.

Career Highlights

Moye Jia is associated with Beijing Migrasome Therapeutics Limited, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to addressing challenges in drug delivery and therapeutic efficacy.

Collaborations

Moye Jia collaborates with notable colleagues, including Li Yu and Dongju Wang. Their combined expertise contributes to the ongoing research and development initiatives at their company.

Conclusion

Moye Jia's contributions to biomedicine through his patented innovations highlight the importance of engineering in enhancing drug delivery systems. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…